Purchase Order 75N92B25P00236

Award Date 7/25/25
Potential Completion Date 1/24/26
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,000 firm fixed price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract has an ultimate completion date of July 4, 2026 and is not set aside. 10X Genomics specializes in single-cell and spatial genomic analysis solutions that support...
This federal contract award was made by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency under the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit biotechnology company headquartered in Pleasanton, California. The $24,861.50 firm-fixed-price purchase order contract has an ultimate completion date of August 20, 2026. The contract does not have a set-aside designation. 10X Genomics specializes in advanced genomic analysis...
This is a $11,000 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The contract is not set aside and does not appear to be part of a larger contract vehicle. Under this contract, 10X Genomics will provide specialized scientific equipment,...
This firm fixed price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to 10X Genomics, Inc., a life sciences technology company, with a potential value of $12,164.00. The contract has a completion date of May 15, 2025 and was awarded on May 16, 2024. The award is not associated with a set-aside designation. Under this contract, 10X Genomics will provide the NIH with specialized kits, instruments, and...
This firm fixed-price purchase order was awarded to 10X Genomics, Inc., a life sciences technology company, by the National Institute on Aging, a part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $53,388 contract provides 10X Genomics' specialized genomic analysis products and services, including kits for single-cell RNA sequencing, single-cell ATAC sequencing, single-cell multi-omics, and spatial transcriptomics, as well as the...
This firm fixed price purchase order contract was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The $11,000.00 contract provides 10X Genomics' products and services for single-cell and spatial analysis applications to support biomedical research. This includes specialized kits, instruments such as the Chromium Controller and Visium Spatial Gene Expression system, as well as...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health (NIH), to 10X Genomics, Inc. The contract, valued at $100,100.00, is for the provision of 10X Genomics' specialized genomics analysis products and services, including kits, instruments, and supporting services for single-cell and spatial analysis applications. The contract supports biomedical...
This firm fixed price purchase order was awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $22,871.25 contract provides 10X Genomics' specialized kits, instruments, and services to support single-cell and spatial analysis research, particularly in the areas of neurological diseases and disorders. 10X Genomics, as a prime contractor, has previously received...
This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $17,332.00 contract is for the delivery of 10X Genomics' products and services for single-cell and spatial analysis applications, including specialized kits, instruments, and associated installation, training, and support services. The contract has a period of...
This is a $95,474.20 firm fixed price delivery order contract awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. to provide single cell RNA sequencing and ATAC sequencing kits. The contract has an ultimate completion date of August 24, 2024. As the prime contractor, 10X Genomics, a life sciences technology company, will supply specialized genomic analysis products and related services to support biomedical research efforts....

This is a $19,248 firm fixed price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of advanced genomic analysis platforms, reagents, and instruments. The contract, which has a completion date of January 24, 2026, does not have a set-aside designation.

10X Genomics is providing specialized scientific equipment, consumables, and research tools to support NIAMS's biomedical research efforts, particularly in areas such as infectious diseases, cancer, neurological disorders, and age-related conditions. The products include Chromium Next GEM Single Cell Kits, Visium Spatial Gene Expression systems, Xenium Analyzers, and related reagents for single-cell RNA sequencing, single-cell ATAC sequencing, multi-omics analysis, and spatial transcriptomics research. This contract is part of 10X Genomics' broader federal contract portfolio, which includes an indefinite delivery contract valued up to $7,000,000 with the National Institute on Aging.

Generated 6/26/25, 9:53 AM